Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

4th Treg Directed Therapies Summit

Evvnt Promotion / evvnt
Archivio
-
17.05.2022 - 19.05.2022  Embassy Suites by Hilton Boston at Logan Airport, 207 Porter Street, 02128 Boston, USA
Time: 09:00 - 17:30
 
Temi della conferenza
As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy.

The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and better than ever before, boasting 2 tracks of unparalleled content to cater to cell-based, and non-cell-based experts alike.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Speakers: Richard Ransohof, Co-Founder and CMO Abata and Venture Partner, Third Rock Ventures, Thomas Wickham, CSO, GentiBio, Jonathan Zalevsky, Chief Research and Development Officer, Nektar Therapeutics and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/991160-2?pid=4832
Mr. Treg Directed Therapies Summit Team
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.0 - USD 5846.0
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Swiss Tropical and Public Health InstituteÖsterreichische Akademie der ÄrzteAnästhesie in Entwicklungsländern e. V.Charité International AcademyAMREF - African Medical and Research FoundationnewTreeCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation